Investigating causal pathways in severe falciparum malaria: A pooled retrospective analysis of clinical studies.
BACKGROUND:Severe falciparum malaria is a medical emergency characterised by potentially lethal vital organ dysfunction. Patient fatality rates even with parenteral artesunate treatment remain high. Despite considerable research into adjuvant therapies targeting organ and tissue dysfunction, none ha...
| Hlavní autoři: | , , , , , , , , |
|---|---|
| Médium: | Journal article |
| Jazyk: | English |
| Vydáno: |
Public Library of Science
2019
|
| _version_ | 1826264790204416000 |
|---|---|
| author | Leopold, S Watson, J Jeeyapant, A Simpson, J Phu, N Hien, T Day, N Dondorp, A White, N |
| author_facet | Leopold, S Watson, J Jeeyapant, A Simpson, J Phu, N Hien, T Day, N Dondorp, A White, N |
| author_sort | Leopold, S |
| collection | OXFORD |
| description | BACKGROUND:Severe falciparum malaria is a medical emergency characterised by potentially lethal vital organ dysfunction. Patient fatality rates even with parenteral artesunate treatment remain high. Despite considerable research into adjuvant therapies targeting organ and tissue dysfunction, none have shown efficacy apart from renal replacement therapy. Understanding the causal contributions of clinical and laboratory abnormalities to mortality is essential for the design and evaluation of novel therapeutic interventions. METHODS AND FINDINGS:We used a structural model causal inference approach to investigate causal relationships between epidemiological, laboratory, and clinical variables in patients with severe falciparum malaria enrolled in clinical trials and their in-hospital mortality. Under this causal model, we analysed records from 9,040 hospitalised children (0-12 years, n = 5,635) and adults (n = 3,405, 12-87 years) with severe falciparum malaria from 15 countries in Africa and Asia who were studied prospectively over the past 35 years. On admission, patient covariates associated with increased in-hospital mortality were severity of acidosis (odds ratio [OR] 2.10 for a 7-mEq/L increase in base deficit [95% CI 1.93-2.28]), renal impairment (OR 1.71 for a 2-fold increase in blood urea nitrogen [95% CI 1.58, 1.86]), coma (OR 3.59 [95% CI 3.07-4.21]), seizures (OR 1.40 [95% CI 1.16-1.68]), shock (OR 1.51 [95% CI 1.14-1.99]), and presumed pulmonary oedema (OR 1.58 [95% CI 1.04-2.39]). Lower in-hospital mortality was associated with moderate anaemia (OR 0.87 for a decrease of 10 percentage points in haematocrit [95% CI 0.80-0.95]). Circulating parasite density was not associated with mortality (OR 1.02 for a 6-fold increase [95% CI 0.94-1.11]), so the pathological effects of parasitaemia appear to be mediated entirely by the downstream effects of sequestration. Treatment with an artemisinin derivative decreased mortality compared with quinine (OR 0.64 [95% CI 0.56-0.74]). These estimates were consistent across children and adults (mainly representing African and Asian patients, respectively). Using inverse probability weighting, transfusion was not estimated to be beneficial in children with admission haematocrit values between 15% and 25% (OR 0.99 [95% CI 0.97-1.02]). Except for the effects of artemisinin treatment and transfusion, causal interpretations of these estimates could be biased by unmeasured confounding from severe bacterial sepsis, immunity, and duration of illness. CONCLUSION:These data suggest that moderate anaemia is associated with a reduced risk of death in severe falciparum malaria. This is possibly a direct causal association. The severe anaemia threshold criteria for a definition of severe falciparum malaria should be reconsidered. |
| first_indexed | 2024-03-06T20:13:30Z |
| format | Journal article |
| id | oxford-uuid:2b608774-65e6-4a3e-896d-78e16dcee587 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T20:13:30Z |
| publishDate | 2019 |
| publisher | Public Library of Science |
| record_format | dspace |
| spelling | oxford-uuid:2b608774-65e6-4a3e-896d-78e16dcee5872022-03-26T12:30:30ZInvestigating causal pathways in severe falciparum malaria: A pooled retrospective analysis of clinical studies.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:2b608774-65e6-4a3e-896d-78e16dcee587EnglishSymplectic Elements at OxfordPublic Library of Science2019Leopold, SWatson, JJeeyapant, ASimpson, JPhu, NHien, TDay, NDondorp, AWhite, NBACKGROUND:Severe falciparum malaria is a medical emergency characterised by potentially lethal vital organ dysfunction. Patient fatality rates even with parenteral artesunate treatment remain high. Despite considerable research into adjuvant therapies targeting organ and tissue dysfunction, none have shown efficacy apart from renal replacement therapy. Understanding the causal contributions of clinical and laboratory abnormalities to mortality is essential for the design and evaluation of novel therapeutic interventions. METHODS AND FINDINGS:We used a structural model causal inference approach to investigate causal relationships between epidemiological, laboratory, and clinical variables in patients with severe falciparum malaria enrolled in clinical trials and their in-hospital mortality. Under this causal model, we analysed records from 9,040 hospitalised children (0-12 years, n = 5,635) and adults (n = 3,405, 12-87 years) with severe falciparum malaria from 15 countries in Africa and Asia who were studied prospectively over the past 35 years. On admission, patient covariates associated with increased in-hospital mortality were severity of acidosis (odds ratio [OR] 2.10 for a 7-mEq/L increase in base deficit [95% CI 1.93-2.28]), renal impairment (OR 1.71 for a 2-fold increase in blood urea nitrogen [95% CI 1.58, 1.86]), coma (OR 3.59 [95% CI 3.07-4.21]), seizures (OR 1.40 [95% CI 1.16-1.68]), shock (OR 1.51 [95% CI 1.14-1.99]), and presumed pulmonary oedema (OR 1.58 [95% CI 1.04-2.39]). Lower in-hospital mortality was associated with moderate anaemia (OR 0.87 for a decrease of 10 percentage points in haematocrit [95% CI 0.80-0.95]). Circulating parasite density was not associated with mortality (OR 1.02 for a 6-fold increase [95% CI 0.94-1.11]), so the pathological effects of parasitaemia appear to be mediated entirely by the downstream effects of sequestration. Treatment with an artemisinin derivative decreased mortality compared with quinine (OR 0.64 [95% CI 0.56-0.74]). These estimates were consistent across children and adults (mainly representing African and Asian patients, respectively). Using inverse probability weighting, transfusion was not estimated to be beneficial in children with admission haematocrit values between 15% and 25% (OR 0.99 [95% CI 0.97-1.02]). Except for the effects of artemisinin treatment and transfusion, causal interpretations of these estimates could be biased by unmeasured confounding from severe bacterial sepsis, immunity, and duration of illness. CONCLUSION:These data suggest that moderate anaemia is associated with a reduced risk of death in severe falciparum malaria. This is possibly a direct causal association. The severe anaemia threshold criteria for a definition of severe falciparum malaria should be reconsidered. |
| spellingShingle | Leopold, S Watson, J Jeeyapant, A Simpson, J Phu, N Hien, T Day, N Dondorp, A White, N Investigating causal pathways in severe falciparum malaria: A pooled retrospective analysis of clinical studies. |
| title | Investigating causal pathways in severe falciparum malaria: A pooled retrospective analysis of clinical studies. |
| title_full | Investigating causal pathways in severe falciparum malaria: A pooled retrospective analysis of clinical studies. |
| title_fullStr | Investigating causal pathways in severe falciparum malaria: A pooled retrospective analysis of clinical studies. |
| title_full_unstemmed | Investigating causal pathways in severe falciparum malaria: A pooled retrospective analysis of clinical studies. |
| title_short | Investigating causal pathways in severe falciparum malaria: A pooled retrospective analysis of clinical studies. |
| title_sort | investigating causal pathways in severe falciparum malaria a pooled retrospective analysis of clinical studies |
| work_keys_str_mv | AT leopolds investigatingcausalpathwaysinseverefalciparummalariaapooledretrospectiveanalysisofclinicalstudies AT watsonj investigatingcausalpathwaysinseverefalciparummalariaapooledretrospectiveanalysisofclinicalstudies AT jeeyapanta investigatingcausalpathwaysinseverefalciparummalariaapooledretrospectiveanalysisofclinicalstudies AT simpsonj investigatingcausalpathwaysinseverefalciparummalariaapooledretrospectiveanalysisofclinicalstudies AT phun investigatingcausalpathwaysinseverefalciparummalariaapooledretrospectiveanalysisofclinicalstudies AT hient investigatingcausalpathwaysinseverefalciparummalariaapooledretrospectiveanalysisofclinicalstudies AT dayn investigatingcausalpathwaysinseverefalciparummalariaapooledretrospectiveanalysisofclinicalstudies AT dondorpa investigatingcausalpathwaysinseverefalciparummalariaapooledretrospectiveanalysisofclinicalstudies AT whiten investigatingcausalpathwaysinseverefalciparummalariaapooledretrospectiveanalysisofclinicalstudies |